Difference between revisions of "Thrombocytopenia and platelet dysfunction"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
m (Text replacement - "'''Use of this site is subject to you reading and agreeing with the terms set forth in the disclaimer.'''" to "'''Use of this site is subject to you reading and agreeing with the terms set forth in the disclaimer. If this is your first time visiting, we suggest you read the tutorial.'''")
Line 1: Line 1:
'''Use of this site is subject to you reading and agreeing with the terms set forth in the [[HemOnc.org_-_A_Hematology_Oncology_Wiki:General_disclaimer|disclaimer]].'''   
+
'''Use of this site is subject to you reading and agreeing with the terms set forth in the [[HemOnc.org_-_A_Hematology_Oncology_Wiki:General_disclaimer|disclaimer]]. If this is your first time visiting, we suggest you read the [[tutorial]].'''   
  
 
==Definition==
 
==Definition==

Revision as of 16:27, 11 December 2017

Use of this site is subject to you reading and agreeing with the terms set forth in the disclaimer. If this is your first time visiting, we suggest you read the tutorial.

Definition

Platelet count < 150 × 109/L.

Evaluation

May consist of:

  • CBC with differential
  • Comprehensive metabolic panel, including liver function tests (LFTs)
  • Vitamin B12
  • Folate
  • Assessment for liver disease, hepatomegaly, fatty liver, splenomegaly
  • Peripheral smear, platelet clumps
  • Clinical history (bleeding, temporality, recent infections), TTP/HUS
  • Thrombotic history (e.g. heparin/HIT)
  • Lifestyle factors (e.g. alcohol)
  • Medications
  • Hepatitis serologies
  • HIV
  • ANA, lupus
  • Pseudothrombocytopenia, EDTA-induced clumping (draw sample in blue top citrate tube)
  • Pregnancy/gestational thrombocytopenia
  • ITP